Patterns of care in the administration of neo-adjuvant chemotherapy for breast cancer. A population-based study

Breast Journal

Volumn 22, Issue 3, 2016, Pages 316-321

  Vugts, Guusje ^a,b   Maaskant Braat, Adriana J G ^a   Nieuwenhuijzen, Grard A P ^a   Roumen, Rudi M H ^c,d   Luiten, Ernest J T ^e   Voogd, Adri C ^b,d,f  

^a CATHARINA HOSPITAL   (Netherlands)

^b Eindhoven Cancer Registry   (Netherlands)

^c MÁXIMA MEDICAL CENTER   (Netherlands)

^d MAASTRICHT UNIVERSITY   (Netherlands)

^e AMPHIA HOSPITAL   (Netherlands)

^f MAASTRICHT UNIVERSITY   (Netherlands)

Author keywords

breast cancer; downsizing; hospital variation; neo adjuvant chemotherapy; sentinel node biopsy

Indexed keywords

ANTINEOPLASTIC AGENT;

ADULT; ARTICLE; BREAST CANCER; CANCER ADJUVANT THERAPY; CANCER PATIENT; CANCER REGISTRY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MIDDLE AGED; NETHERLANDS; PARTIAL MASTECTOMY; PATIENT CARE; POPULATION RESEARCH; SENTINEL LYMPH NODE BIOPSY; SYSTEMIC THERAPY; TREATMENT INDICATION; TUMOR VOLUME; AGED; BREAST NEOPLASMS; HOSPITAL; NEOADJUVANT THERAPY; PATHOLOGY; PROCEDURES; STATISTICS AND NUMERICAL DATA; UTILIZATION;

AGED; BREAST NEOPLASMS; FEMALE; HOSPITALS; HUMANS; MASTECTOMY, SEGMENTAL; MIDDLE AGED; NEOADJUVANT THERAPY; NETHERLANDS; SENTINEL LYMPH NODE BIOPSY;

EID: 84959508716     PISSN: 1075122X     EISSN: 15244741     Source Type: Journal    
DOI: 10.1111/tbj.12568     Document Type: Article

References (30)

1. Liu SV, Melstrom L, Yao K, et al,. Neoadjuvant therapy for breast cancer. J Surg Oncol 2010; 101: 283-91.
2. Mieog JS, van der Hage JA, van de Velde CJ,. Neoadjuvant chemotherapy for operable breast cancer. Br J Surg 2007; 94: 1189-200.
3. Smith IE, Lipton L,. Preoperative/neoadjuvant medical therapy for early breast cancer. Lancet Oncol 2001; 2: 561-70.
4. Bear HD, Anderson S, Smith RE, et al,. Sequential preoperative or postoperative docetaxel added to preoperative doxorubicin plus cyclophosphamide for operable breast cancer: National Surgical Adjuvant Breast and Bowel Project Protocol B-27. J Clin Oncol 2006; 24: 2019-27.
5. Shin HC, Han W, Moon HG, et al,. Breast-conserving surgery after tumor downstaging by neoadjuvant chemotherapy is oncologically safe for stage III breast cancer patients. Ann Surg Oncol 2013; 20: 2582-9.
6. Cho JH, Park JM, Park HS, et al,. Oncologic safety of breast-conserving surgery compared to mastectomy in patients receiving neoadjuvant chemotherapy for locally advanced breast cancer. J Surg Oncol 2013; 108: 531-6.
7. Lyman GH, Giuliano AE, Somerfield MR, et al,. American Society of Clinical Oncology guideline recommendations for sentinel lymph node biopsy in early-stage breast cancer. J Clin Oncol 2005; 23: 7703-20.
8. Kim T, Giuliano AE, Lyman GH,. Lymphatic mapping and sentinel lymph node biopsy in early-stage breast carcinoma: a metaanalysis. Cancer 2006; 106: 4-16.
9. Chung A, Giuliano A,. Axillary staging in the neoadjuvant setting. Ann Surg Oncol 2010; 17: 2401-10.
10. Stell VH, Flippo-Morton TS, James Norton H, White RL Jr,. Sentinel lymph node biopsy after neo-adjuvant chemotherapy in breast cancer. Breast J 2010; 17: 71-4.
11. Park S, Park JM, Cho JH, et al,. Sentinel lymph node biopsy after neoadjuvant chemotherapy in patients with cytologically proven node-positive breast cancer at diagnosis. Ann Surg Oncol 2013; 20: 2858-65.
12. Dominici LS, Negron Gonzalez VM, Buzdar AU, et al,. Cytologically proven axillary lymph node metastases are eradicated in patients receiving preoperative chemotherapy with concurrent trastuzumab for HER2-positive breast cancer. Cancer 2010; 116: 2884-9.
13. van Deurzen CH, Vriens BE, Tjan-Heijnen VC, et al,. Accuracy of sentinel node biopsy after neoadjuvant chemotherapy in breast cancer patients: a systematic review. Eur J Cancer 2009; 45: 3124-30.
14. Schwartz GF, Tannebaum JE, Jernigan AM, Palazzo JP,. Axillary sentinel lymph node biopsy after neoadjuvant chemotherapy for carcinoma of the breast. Cancer 2010; 116: 1243-51.
15. Schouten LJ, Hoppener P, van den Brandt PA, et al,. Completeness of cancer registration in Limburg, The Netherlands. Int J Epidemiol 1993; 22: 369-76.
16. UICC. TNM Classification of Malignant Tumours, 7th edn. New York: Wiley-Blackwell, 2009.
17. Boyages J, Taylor R, Chua B, et al,. A risk index for early node-negative breast cancer. Br J Surg 2006; 93: 564-71.
18. Lundin J, Lehtimaki T, Lundin M, et al,. Generalisability of survival estimates for patients with breast cancer-a comparison across two population-based series. Eur J Cancer 2006; 42: 3228-35.
19. Olivotto IA, Bajdik CD, Ravdin PM, et al,. Population-based validation of the prognostic model ADJUVANT! for early breast cancer. J Clin Oncol 2005; 23: 2716-25.
20. McVeigh TP, Al-Azawi D, Kearney DE, et al,. Assessing the impact of neoadjuvant chemotherapy on the management of the breast and axilla in breast cancer. Clin Breast Cancer 2014; 14: 20-5.
21. Mauri D, Pavlidis N, Ioannidis JP,. Neoadjuvant versus adjuvant systemic treatment in breast cancer: a meta-analysis. J Natl Cancer Inst 2005; 97: 188-94.
22. van Riet YE, Jansen FH, van Beek M, et al,. Localization of non-palpable breast cancer using a radiolabelled titanium seed. Br J Surg 2010; 97: 1240-5.
23. van Riet YE, Maaskant AJ, Creemers GJ, et al,. Identification of residual breast tumour localization after neo-adjuvant chemotherapy using a radioactive 125 Iodine seed. Eur J Surg Oncol 2010; 36: 164-9.
24. Gobardhan PD, de Wall LL, van der Laan L, et al,. The role of radioactive iodine-125 seed localization in breast-conserving therapy following neoadjuvant chemotherapy. Ann Oncol 2013; 24: 668-73.
25. van Steenbergen LN, van de Poll-Franse LV, Wouters MW, et al,. Variation in management of early breast cancer in the Netherlands, 2003-2006. Eur J Surg Oncol 36 (Suppl 1): S36-43.
26. NABON. Richtlijn behandeling van het mammacarcinoom, 2012. Available at: http://www.oncoline.nl (accessed November 1, 2014).
27. Mamounas EP, Anderson SJ, Dignam JJ, et al,. Predictors of locoregional recurrence after neoadjuvant chemotherapy: results from combined analysis of National Surgical Adjuvant Breast and Bowel Project B-18 and B-27. J Clin Oncol 2012; 30: 3960-6.
28. Thomas S, Prakash A, Goyal V, et al,. Evaluation of sentinel node biopsy in locally advanced breast cancer patients who become clinically node-negative after neoadjuvant chemotherapy: a preliminary study. Int J Breast Cancer 2011; 2011: 870263.
29. Boughey JC, Suman VJ, Mittendorf EA, et al,. Sentinel lymph node surgery after neoadjuvant chemotherapy in patients with node-positive breast cancer: the ACOSOG Z1071 (Alliance) clinical trial. JAMA 2013; 310: 1455-61.
30. Kuehn T, Bauerfeind I, Fehm T, et al,. Sentinel-lymph-node biopsy in patients with breast cancer before and after neoadjuvant chemotherapy (SENTINA): a prospective, multicentre cohort study. Lancet Oncol 2013; 14: 609-18.